Li Dean Y 内部人交易：近期 SEC Form 4 交易
过去 18 个月，Li Dean Y（CIK 1837016）在 2 家公司共报告 14 笔 SEC Form 4 内部人交易（最近一笔 2026-10-02）。
| 日期 | 公司 | 身份 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-10-02 | RECURSION PHARMACEUTICALS, INC. (RXRX) | 董事 | 买入 | 3,378 | $0 |
| 2026-07-02 | RECURSION PHARMACEUTICALS, INC. (RXRX) | 董事 | 买入 | 3,747 | $0 |
| 2026-06-22 | RECURSION PHARMACEUTICALS, INC. (RXRX) | 董事 | 买入 | 88,424 | $0 |
| 2026-05-01 | Merck & Co., Inc. (MRK) | Executive VP & President, MRL | 买入 | 4,722 | $519,562 |
| 2026-05-01 | Merck & Co., Inc. (MRK) | Executive VP & President, MRL | 卖出 | 2,326 | $255,930 |
| 2026-04-02 | RECURSION PHARMACEUTICALS, INC. (RXRX) | 董事 | 买入 | 3,268 | $0 |
| 2026-02-10 | Merck & Co., Inc. (MRK) | Executive VP & President, MRL | 卖出 | 10,235 | $1.2M |
| 2026-02-06 | Merck & Co., Inc. (MRK) | Executive VP & President, MRL | 买入 | 15,087 | $845,475 |
| 2026-02-06 | Merck & Co., Inc. (MRK) | Executive VP & President, MRL | 卖出 | 15,087 | $1.8M |
| 2026-01-28 | Merck & Co., Inc. (MRK) | Executive VP & President, MRL | 买入 | 20,469 | $2.2M |
| 2026-01-06 | RECURSION PHARMACEUTICALS, INC. (RXRX) | 董事 | 买入 | 2,381 | $0 |
| 2025-10-03 | RECURSION PHARMACEUTICALS, INC. (RXRX) | 董事 | 买入 | 1,961 | $0 |
| 2025-07-03 | RECURSION PHARMACEUTICALS, INC. (RXRX) | 董事 | 买入 | 1,949 | $0 |
| 2025-06-23 | RECURSION PHARMACEUTICALS, INC. (RXRX) | 董事 | 买入 | 22,016 | $0 |
来源：SEC Form 4 申报文件 · 截至 2026-10-02